GLS and neoplasm: Notably, blocking glutamine metabolic coupling by knocking down GPER and/or GLUL in CAFs resulted in reduced glutamine production (Figure 6D) and decreased expression of ASCT2 and GLS1 in tumours (Figure 6E,F).